Imipenem and Cilastatin for Injection USP 500 mg (Imipenem POWDER FOR SOLUTION) 500 MG

Imipenem and Cilastatin for Injection USP 500 mg is a powder for solution used for intravenous administration. This antibiotic combination is designed to treat a variety of bacterial infections. Learn more about its uses and effects.

Strength

500 MG

Pack Size

Manufacturer / TM Owner

SANDOZ CANADA INCORPORATED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Imipenem and Cilastatin for Injection USP 500 mg is primarily used to treat bacterial infections. This combination drug works by stopping the growth of bacteria, making it effective for what is Imipenem used for in severe infections. It is often prescribed for conditions requiring broad-spectrum antibiotic coverage.

Side Effects

Common effects of Imipenem and Cilastatin for Injection USP 500 mg may include nausea, diarrhea, and rash. Some individuals might experience more severe reactions, so it's important to monitor for any adverse effects. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Handle Imipenem and Cilastatin for Injection USP 500 mg with care, ensuring proper storage and preparation. It should be administered under medical supervision to minimize risks. Follow all safety guidelines provided with the medication.

Avoid Interactions

Imipenem and Cilastatin for Injection USP 500 mg may interact with other medications, including certain antibiotics and diuretics. Always inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect its efficacy.

Frequently Asked Questions

It is used to treat a variety of bacterial infections, often in severe cases requiring broad-spectrum antibiotic coverage.

This medication is administered intravenously as a powder for solution, typically under medical supervision.

Common side effects may include nausea, diarrhea, and rash. Severe reactions are less common but possible.

It may interact with other medications, so it's important to consult a healthcare provider before combining it with other treatments.

Proper storage, preparation, and administration under medical supervision are essential to minimize risks.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.